Ophthalmic Pharmacology Practice Questions

Q: Which alpha-2 agonist is used in the management of glaucoma?

Brimonidine. **Explanation:** **Brimonidine** is a highly selective **alpha-2 adrenergic agonist** used as a first-line or adjunctive treatment in open-angle glaucoma and ocular hypertension. It lowers intraocular pressure (IOP) through a unique **dual mechanism**: 1. It reduces the production of aqueous humor by the ciliary body. 2. It increases aqueous outflow via the **uveoscleral pathway**. Additionally, it is often cited for its potential **neuroprotective** properties on retinal ganglion cells. **Analysis of Incorrect Options:** * **B. Timolol:** This is a **non-selective beta-blocker**. While it is a mainstay in glaucoma therapy, it works by decreasing aqueous production, not by alpha-2 stimulation. * **C. Phenylephrine:** This is a selective **alpha-1 agonist**. In ophthalmology, it is used primarily as a mydriatic (to dilate the pupil) for fundus examination, not for lowering IOP. In fact, it can precipitate acute angle-closure in predisposed eyes. * **D. Reserpine:** This is an older antihypertensive agent that acts as a vesicular monoamine transporter (VMAT) inhibitor, leading to the depletion of catecholamines. It has no role in the management of glaucoma. **High-Yield Clinical Pearls for NEET-PG:** * **Apraclonidine** is another alpha-2 agonist, primarily used to prevent post-laser IOP spikes. * **Side Effects:** Brimonidine is notorious for causing **allergic conjunctivitis** (follicular reaction). * **Contraindication:** It is strictly contraindicated in **infants and young children** (under 2 years) as it can cross the blood-brain barrier and cause CNS depression, apnea, and bradycardia.

Q: What is the typical percentage of tetracaine used in eye surgery?

0.50%. **Explanation:** Tetracaine (Amethocaine) is a potent ester-type local anesthetic widely used in ophthalmology for topical anesthesia. **1. Why 0.50% is correct:** The standard commercial preparation of tetracaine for ophthalmic use is **0.5%**. At this concentration, it provides rapid onset of action (within 30 seconds) and a duration of anesthesia lasting approximately 15–20 minutes. It is primarily used for short procedures such as tonometry, foreign body removal, and as a supplement in cataract surgery. **2. Why the other options are incorrect:** * **1%:** While 1% tetracaine exists in some formulations, it is significantly more toxic to the corneal epithelium and is not the standard concentration for routine eye surgery. * **2% and 4%:** These higher concentrations are typically reserved for topical anesthesia in ENT procedures (e.g., oropharyngeal or nasal mucosa) or for spinal anesthesia. In the eye, such high concentrations would cause severe epithelial sloughing and delayed wound healing. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** It works by blocking voltage-gated sodium channels, preventing the generation and conduction of nerve impulses. * **Corneal Toxicity:** All topical anesthetics, especially tetracaine, are **epitheliotoxic**. They inhibit corneal epithelial healing and can lead to "neurotrophic keratitis" if abused. * **Contraindication:** Never prescribe topical anesthetics for home use by the patient due to the risk of "Anesthetic Abuse Keratopathy" and corneal melting. * **Comparison:** Proparacaine (0.5%) is often preferred over tetracaine because it causes less stinging/burning sensation upon instillation.

Q: Which of the following anti-glaucoma drugs can cause heterochromia iridis?

Latanoprost. **Explanation:** **Latanoprost** is a Prostaglandin F2α (PGF2α) analogue. It is a first-line agent for Open-Angle Glaucoma because it increases the **uveoscleral outflow** of aqueous humor. **Why Latanoprost is correct:** Prostaglandin analogues (Latanoprost, Bimatoprost, Travoprost) are notorious for causing **increased pigmentation of the iris**, leading to **heterochromia iridis** (a difference in coloration between the two eyes). This occurs because these drugs stimulate **melanogenesis** within the stromal melanocytes of the iris. Importantly, this is due to an increase in melanin production, not an increase in the number of melanocytes (no hyperplasia). **Why the other options are incorrect:** * **Timolol (Option A):** A non-selective beta-blocker that reduces aqueous production. Common side effects include stinging, dry eyes, and systemic bradycardia/bronchospasm, but it does not affect iris color. * **Apraclonidine (Option C):** An alpha-2 agonist that reduces aqueous production and increases outflow. It is known for causing lid retraction and follicular conjunctivitis, but not iris pigmentation. * **Acetazolamide (Option D):** A systemic carbonic anhydrase inhibitor. It causes metabolic acidosis, paresthesia, and hypokalemia, but has no local effect on iris melanocytes. **High-Yield Clinical Pearls for NEET-PG:** * **Prostaglandin Side Effects (Triple P):** **P**igmentation (Iris/Eyelid), **P**rominence of lashes (Hypertrichosis), and **P**seudophakic Cystoid Macular Edema (CME). * **Mechanism:** Increases uveoscleral outflow (the "alternative" pathway). * **Contraindication:** Avoid in patients with active uveitis or history of Herpetic Keratitis, as it can exacerbate inflammation.

Q: A 60-year-old patient requires an eye examination. Which drug, used to dilate the pupils, does not paralyze the ciliary muscle?

Phenylephrine. **Explanation:** The correct answer is **Phenylephrine**. To understand why, we must distinguish between two mechanisms of pupillary dilation: 1. **Sympathomimetics (Adrenergic Agonists):** Phenylephrine acts on the **$\alpha_1$-adrenergic receptors** of the iris dilator muscle. It causes **Mydriasis** (dilation) without affecting the ciliary muscle. Since the ciliary muscle is controlled by the parasympathetic system, Phenylephrine does not cause cycloplegia (paralysis of accommodation). 2. **Parasympatholytics (Antimuscarinics):** These drugs block the **M3 receptors** on the iris sphincter (causing mydriasis) AND the ciliary muscle (causing cycloplegia). **Analysis of Options:** * **Phenylephrine (B):** A pure $\alpha_1$ agonist. It is a **non-cycloplegic mydriatic**. It is ideal for routine fundus examinations in adults where blurring of vision (due to loss of accommodation) is undesirable. * **Atropine (A):** The most potent cycloplegic and mydriatic. It has a long duration of action (up to 7–10 days) and is never used for routine refraction. * **Cyclopentolate (C):** A potent cycloplegic used commonly for refraction in children. * **Tropicamide (D):** The shortest-acting antimuscarinic. While it is the drug of choice for routine fundus exams, it still possesses some cycloplegic effect, unlike Phenylephrine. **NEET-PG High-Yield Pearls:** * **Drug of choice for Refraction:** Children (Atropine/Cyclopentolate); Adults (Tropicamide). * **Phenylephrine Test:** Used to differentiate episcleritis (blanches/whitens) from scleritis (does not blanch). * **Caution:** Avoid Phenylephrine in patients with narrow-angle glaucoma and use with caution in hypertensive patients or those on MAO inhibitors. * **Mydriatic of choice for premature infants:** Phenylephrine 2.5% (to avoid systemic toxicity of higher concentrations).

Q: Bimatoprost is used in:

Glaucoma. **Explanation:** **Bimatoprost** is a synthetic **prostamide (prostaglandin F2α analog)**. It is primarily used as a first-line treatment for **Open-Angle Glaucoma** and Ocular Hypertension. It works by increasing the outflow of aqueous humor through both the **uveoscleral pathway** (primary mechanism) and the trabecular meshwork, thereby effectively lowering intraocular pressure (IOP). **Analysis of Options:** * **A. Glaucoma (Correct):** As a potent hypotensive agent, it is preferred due to its once-daily dosing and high efficacy in reducing IOP. * **B. Barrett's Esophagus:** This is a premalignant condition of the esophagus; Bimatoprost has no role in its management. * **C. Hypertrichosis of eyelid:** This is actually a **side effect** of Bimatoprost, not a condition it is used to treat. However, a specific formulation is FDA-approved for *eyelash hypotrichosis* (to increase growth), but "hypertrichosis" refers to excessive hair, which is an adverse effect in the context of glaucoma therapy. * **D. NSAID ulcer:** Prostaglandin analogs like **Misoprostol** (PGE1) are used for NSAID-induced ulcers, not Bimatoprost. **High-Yield Clinical Pearls for NEET-PG:** 1. **Side Effects:** The most characteristic side effects include **iris heterochromia** (permanent darkening of iris pigment), eyelash thickening/darkening, and prostaglandin-associated periorbitopathy. 2. **Mechanism:** Remember that PG analogs primarily target the **uveoscleral outflow**. 3. **Contraindication:** Avoid in patients with active intraocular inflammation (uveitis) or cystoid macular edema (CME). 4. **Other PG Analogs:** Latanoprost, Travoprost, and Tafluprost.

Q: All of the following agents are used in glaucoma treatment, except?

Metoprolol. **Explanation:** The management of glaucoma focuses on reducing intraocular pressure (IOP) by either decreasing aqueous humor production or increasing its outflow. **Why Metoprolol is the correct answer:** While beta-blockers are a mainstay in glaucoma therapy, they must be applied **topically** to the eye to be effective. **Metoprolol** is a cardioselective $\beta_1$-blocker primarily used systemically for hypertension and cardiac conditions; it is not available or used as an ophthalmic preparation for glaucoma. In contrast, topical beta-blockers used in glaucoma (like Timolol or Betaxolol) work by blocking $\beta$-receptors in the ciliary body, thereby reducing aqueous production. **Analysis of incorrect options:** * **Apraclonidine:** An $\alpha_2$-adrenergic agonist. It reduces IOP by decreasing aqueous production and increasing uveoscleral outflow. It is frequently used to prevent IOP spikes after laser procedures (e.g., iridotomy). * **Timolol:** A non-selective $\beta$-blocker and the "gold standard" first-line topical agent for many years. It reduces aqueous humor secretion from the ciliary epithelium. * **Pilocarpine:** A direct-acting miotic (cholinergic agonist). It increases aqueous outflow by contracting the ciliary muscle, which pulls on the scleral spur and opens the trabecular meshwork. It is the drug of choice in acute angle-closure glaucoma. **High-Yield Clinical Pearls for NEET-PG:** * **Betaxolol** is the only **cardioselective ($\beta_1$)** topical beta-blocker; it is safer (though not absolute) in patients with asthma/COPD compared to Timolol. * **Latanoprost (Prostaglandin analog)** is currently the overall first-line treatment for Open Angle Glaucoma due to its once-daily dosing and superior efficacy. * **Apraclonidine side effect:** Long-term use is limited by a high incidence of local allergic reactions (blepharoconjunctivitis).

Q: Which miotic agent is used in the management of glaucoma?

Pilocarpine. **Explanation:** **Pilocarpine** is the correct answer because it is a direct-acting parasympathomimetic (cholinergic agonist) that acts primarily on **M3 receptors**. In the eye, it causes contraction of the **sphincter pupillae** (miosis) and the **ciliary muscle**. Contraction of the ciliary muscle pulls on the scleral spur, opening the trabecular meshwork spaces and increasing aqueous outflow. It is the drug of choice for **Acute Angle Closure Glaucoma** (pre-operatively) to pull the peripheral iris away from the angle. **Analysis of Incorrect Options:** * **Methacholine (A):** Primarily used in the "Methacholine Challenge Test" to diagnose bronchial hyperreactivity (Asthma). It is rarely used in ophthalmology due to its lack of selectivity and short duration of action. * **Cevimeline (C):** A cholinergic agonist with high affinity for M3 receptors, but it is specifically indicated for **Sjogren’s syndrome** to treat xerostomia (dry mouth). * **Bethanechol (D):** Acts mainly on the bladder and GI tract. It is used to treat **postoperative urinary retention** and adynamic ileus, not glaucoma. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism in Glaucoma:** Increases trabecular outflow (not uveoscleral). * **Adverse Effects:** Brow ache (due to ciliary muscle spasm), induced myopia, and increased risk of **retinal detachment** (due to traction on the retina). * **Adie’s Tonic Pupil:** Diagnosed using **0.125% Pilocarpine**; the denervated pupil shows hypersensitivity and constricts, while a normal pupil does not. * **Contraindication:** It should be avoided in young patients (due to myopic shift) and patients with secondary glaucoma caused by uveitis (risk of posterior synechiae).

Question 1

What are the potential complications of using topical steroids?

Accepted Answer

Glaucoma

Answer

Cataract

Answer

Uveitis

Answer

None of the above

Question 2

Which alpha-2 agonist is used in the management of glaucoma?

Accepted Answer

Brimonidine

Answer

Timolol

Answer

Phenylephrine

Answer

Reserpine

Question 3

What is the typical percentage of tetracaine used in eye surgery?

Accepted Answer

0.50%

Answer

1%

Answer

2%

Answer

4%

Question 4

What is the concentration of tetracycline ointment used for mass prophylaxis?

Accepted Answer

1%

Answer

0.10%

Answer

0.50%

Answer

5%

Question 5

Which of the following anti-glaucoma drugs can cause heterochromia iridis?

Accepted Answer

Latanoprost

Answer

Timolol

Answer

Apraclonidine

Answer

Acetazolamide

Question 6

A 60-year-old patient requires an eye examination. Which drug, used to dilate the pupils, does not paralyze the ciliary muscle?

Accepted Answer

Phenylephrine

Answer

Atropine

Answer

Cyclopentolate

Answer

Tropicamide

Question 7

Bimatoprost is used in:

Accepted Answer

Glaucoma

Answer

Barrett's esophagus

Answer

Hypertrichosis of eyelid

Answer

NSAID ulcer

Question 8

All of the following agents are used in glaucoma treatment, except?

Accepted Answer

Metoprolol

Answer

Apraclonidine

Answer

Timolol

Answer

Pilocarpine

Question 9

What is the drug of choice for anterior uveitis?

Accepted Answer

Topical steroids

Answer

Oral steroids

Answer

Topical antibiotics

Answer

Atropine

Question 10

Which miotic agent is used in the management of glaucoma?

Accepted Answer

Pilocarpine

Answer

Methacholine

Answer

Cevimeline

Answer

Bethanechol

Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?